Skip to main content

Table 2 Frequency of anti-HCV ELISA reactivity and HCV infection in the 4 different studied subgroups.

From: Hepatitis B virus infection in Haemodialysis Centres from Santa Catarina State, Southern Brazil. Predictive risk factors for infection and molecular epidemiology

Group

n

Anti-HCV +ve

HCV infection*

Haemodialysis Patients (HP)

813

276 (33.9%)

274 (33.4%)

HP Controls

623

7 (1.1%)

5 (0.8%)

Health care Workers (HCW)

149

7 (4.7%)

4 (2.7%)

HCW Controls

149

0

0

  1. * anti-HCV positive by ELISA and immunoblot or PCR positive. +ve = positive